Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
05/2003
05/06/2003US6559162 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
05/06/2003US6559157 Dihydronaphthalene compounds
05/06/2003US6559143 Class III electrophysiological activity, drugs which prolong the trans-membrane action potential duration and refractoriness, without affecting cardiac conduction
05/06/2003US6558710 Zinc oxide, its hydrated complex with glycine or lycine and free anhydrous glycine; healing skin; minimizing irritation without loss of efficacy
05/06/2003CA2186017C Soap composition
05/02/2003EP1305045A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications
05/02/2003EP1194186B1 CARDIOACTIVE COMPOSITION COMPRISING L-CARNITINE AND ITS DERIVATIVES AND i CRATAEGUS /i EXTRACTS
05/02/2003EP1140115B1 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
05/02/2003EP0998260B1 Oxidation dyeing composition for keratin fibres and dyeing method using said composition
05/02/2003EP0984957B1 Novel form of s-omeprazole
05/02/2003EP0966258B1 Antiperspirant or deodorant composition
05/01/2003WO2003035085A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
05/01/2003WO2003035072A1 Use of flibanserin in the treatment of sexual disorders
05/01/2003WO2003035068A1 Macrolides containing pharmaceutical compositions
05/01/2003WO2003035009A2 Treatment of acute myeloid leukemia with indolinone compounds
05/01/2003WO2003035001A2 Anti-hsv agent for inhibiting replication of hsv-1 and hsv-2 and method of producing a substance having anti-hsv activity
05/01/2003WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003WO2003007912A3 Lyophilized formulation comprising olanzapine
05/01/2003WO2002096435A3 Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
05/01/2003WO2002043739A3 Dermatological formulations containing clindamycin and a zinc-salt
05/01/2003US20030083347 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
05/01/2003US20030082158 Production of transduced hematopoietic progenitor cells
05/01/2003US20030082155 Antidiabetic agents; cell differentiation of stem cells
05/01/2003CA2842429A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2675409A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2464790A1 Treatment of acute myeloid leukemia with indolinone compounds
05/01/2003CA2464460A1 In vitro micro-organs, and uses related thereto
05/01/2003CA2464331A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
05/01/2003CA2461665A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
04/2003
04/30/2003CN1414860A Treatment of infertility
04/30/2003CN1413728A Traditional Chinese medicine composition for treating coronary heart disease and its preparation method
04/30/2003CN1413724A Brain active effect matter for prevention and curing encephalopathy and developing intelligence and its preparation method
04/30/2003CN1413648A Chinese medicine composite for treating vomiting and diarrhea and its preparation method
04/29/2003US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery
04/29/2003US6555689 Intermediates useful for the preparation of antihistaminic piperidine derivatives
04/29/2003US6555550 Musarinic agonists and antagonists
04/29/2003US6555518 2',2'-difluoronucleosides for suppressing rejection of transplants in mammals; for treatment of autoimmune diseases
04/29/2003US6555134 Synergistic mixtures of garlic and lycopene for preventing LDL oxidation
04/29/2003CA2129473C Hair coloring composition
04/29/2003CA2123160C Controlled release formulation
04/29/2003CA2105813C Method of increasing hair shine and repairing alkaline-damaged hair
04/29/2003CA2103571C Method of treating pulmonary inflammation
04/24/2003WO2003033466A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
04/24/2003WO2003032995A1 Rosuvastatin in pre demented states
04/24/2003WO2003032973A2 Composition comprising paracetamol and a bitterness masking component
04/24/2003WO2003032950A1 Pharmaceutical formulation comprising (r) -bicalutamide
04/24/2003WO2003032904A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)
04/24/2003WO2003032893A2 Assignment
04/24/2003WO2003032810A2 Treatment and diagnosis of insulin resistant states
04/24/2003WO2002097072A3 Influenza vaccine composition
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078261 Prostaglandin agonists
04/24/2003US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases
04/24/2003US20030077332 Wound healing agents; viricides
04/24/2003US20030074747 Composition for the oxidation dyeing of keratin fibres, comprising at least one fatty alcohol chosen from mono- and polyglycerolated fatty alcohols and a particular polyol
04/24/2003CA2463655A1 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)
04/24/2003CA2463597A1 Rosuvastatin in pre demented states
04/24/2003CA2463016A1 Composition comprising paracetamol and a bitterness masking component
04/24/2003CA2462219A1 Pharmaceutical formulation comprising (r) -bicalutamide
04/24/2003CA2461818A1 Treatment and diagnosis of insulin resistant states
04/23/2003EP1304338A1 Process for the preparation of Chondroitin sulfates from K4 Polysaccharide and obtained products
04/23/2003EP1304110A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
04/23/2003EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
04/23/2003EP1303514A1 Process for preparing azacycloalkanoylaminothiazoles
04/23/2003EP1303513A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
04/23/2003EP1175428B1 3-deoxy-desmycosin derivatives and process for their preparation
04/23/2003EP0993442B1 Hydrazine derivatives
04/23/2003EP0831898B1 Modified meningococcal polysaccharide conjugate vaccines
04/23/2003EP0796111B1 In-vivo diagnostic process by near infrared radiation using cyanine dyes
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/23/2003CN1413196A 2-Arylquinoline derivatives, preparation and therapeutic use thereof
04/23/2003CN1413190A EP4 receptor selective agonists in treatment of osteoporosis
04/23/2003CN1413103A Agent for dyeing keratin containing fibers
04/23/2003CN1411812A Oral medicine preparation with high absorbency
04/22/2003US6552206 Isolated n-benzyl-9-oxo-16-hydroxy-octadeca-10,12,14-triene amide; treating and preventing cancer and sexual dysfunction
04/22/2003US6552200 Intermediates useful for the preparation of antihistaminic piperidine derivatives
04/22/2003US6552067 EP4 receptor selective agonists in the treatment of osteoporosis
04/22/2003US6552024 For administering agents in a dissolving film configuration; drug delivery
04/22/2003US6551602 Conjugated linoleic acid (CLA) compound in cis9 trans11 and trans10 cis 12 isomer forms, and epigallocatechin gallate, genistein, green tea extract and/or soy extract; treating wrinkles and soothing sensitive
04/22/2003CA2408681A1 Process for the preparation of chondroitin sulfates from k4 polysaccharide and obtained products
04/22/2003CA2292673C Pharmaceutical compositions containing eletriptan hemisulphate
04/17/2003WO2003030993A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003WO2003030893A1 Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue
04/17/2003WO2003030830A2 Method and apparatus for improved stiffness in the linkage assembly of a flexible arm
04/17/2003WO2003030823A2 Combinations for the treatment of immunoinflammatory disorders
04/17/2003WO2001094341A9 Quinazoline derivatives for the treatment of tumours
04/17/2003US20030073719 Chiral salt resolution
04/17/2003US20030073700 Central nervous system disorders; Parkinson's disease, Huntington's disease; psycological disorders
04/17/2003CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003CA2462886A1 Flashmelt oral dosage formulation
04/17/2003CA2462272A1 Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue
04/16/2003WO2003032915A2 Viral inhibition by n-docosanol
04/16/2003EP1301200A2 Peptide pharmaceutical formulations
04/16/2003EP1218022B1 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
04/16/2003EP1090027B1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
04/16/2003EP1079794A4 Method and system for color customizing cosmetic mass products
04/16/2003EP0966264B1 Cleansing composition with separately dispensed cleansing base and benefit base wherein benefit base also comprises surfactant
04/16/2003EP0885000B1 Topical compositions comprising an oil-in-water emulsion and a retinoid
1 ... 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 ... 295